Literature DB >> 30172777

Histone demethylase JARID1B regulates proliferation and migration of pulmonary arterial smooth muscle cells in mice with chronic hypoxia-induced pulmonary hypertension via nuclear factor-kappa B (NFkB).

Yuanshi Li1, Sining Liu2, Yihong Zhang3, Qianping Gao1, Weiju Sun1, Lu Fu1, Junxian Cao4.   

Abstract

Chronic hypoxia-induced pulmonary hypertension (PH) is a disorder that is characterized by increased pulmonary arterial pressure resulting from lung diseases or shortage of oxygen in the body. Excess proliferation of pulmonary vascular cells such as pulmonary artery endothelial cells (PAECs) and pulmonary artery smooth muscle cells (PASMCs) plays a critical role in the pathogenesis of PH. Recent evidence indicates that, in addition to genetic predisposition and environmental factors, epigenetic mechanisms play a pivotal role in etiology of PH. In this study, we investigated the possible role played by jumonji AT-rich interactive domain 1B (JARID1B), a histone demethylase, in regulating the proliferation of vascular smooth muscle cells in chronic hypoxia-induced PH condition. Quantitative polymerase chain reaction analysis of samples from rats with PH showed an elevated expression of JARID1B in their PASMCs, positively correlating with increased nuclear factor-kappa B (NFkB) expression. Further functional studies in vitro indicated that overexpression of JARID1B increased the proliferation and migration of PASMCs, which were inhibited by depletion of NFkB. Genomewide transcriptional analysis revealed that the JARID1B regulated NFkB signaling pathway by directly binding to its promoter. We have also shown that JARID1B indirectly regulates the expression of vascular endothelial growth factor via NFkB signaling and hence may also play a crucial role in controlling PAECs, leading to changes in vascular architecture in PH. Our findings could lead to further studies on the role of JARID1B in PH etiology and therefore could lead to a potential therapeutic target for chronic hypoxia induced pulmonary hypertension.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  JARID1B; NFkB; Pulmonary hypertension; Vascular smooth muscle cell

Mesh:

Substances:

Year:  2018        PMID: 30172777     DOI: 10.1016/j.carpath.2018.07.004

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  5 in total

1.  The effect of ellagic acid on caspase-3/bcl-2/Nrf-2/NF-kB/TNF-α /COX-2 gene expression product apoptosis pathway: a new approach for muscle damage therapy.

Authors:  Abdullah Aslan; Seda Beyaz; Ozlem Gok; Orhan Erman
Journal:  Mol Biol Rep       Date:  2020-03-02       Impact factor: 2.316

2.  The Functional Interaction of EGFR with AT1R or TP in Primary Vascular Smooth Muscle Cells Triggers a Synergistic Regulation of Gene Expression.

Authors:  Virginie Dubourg; Barbara Schreier; Gerald Schwerdt; Sindy Rabe; Ralf A Benndorf; Michael Gekle
Journal:  Cells       Date:  2022-06-16       Impact factor: 7.666

3.  SEDT2/METTL14-mediated m6A methylation awakening contributes to hypoxia-induced pulmonary arterial hypertension in mice.

Authors:  Xue-Liang Zhou; Feng-Jian Huang; Yang Li; Huang Huang; Qi-Cai Wu
Journal:  Aging (Albany NY)       Date:  2021-02-26       Impact factor: 5.682

Review 4.  Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension.

Authors:  Jaylen Hudson; Laszlo Farkas
Journal:  Int J Mol Sci       Date:  2021-11-09       Impact factor: 5.923

5.  Endothelial Twist1-PDGFB signaling mediates hypoxia-induced proliferation and migration of αSMA-positive cells.

Authors:  Akiko Mammoto; Tadanori Mammoto; Kathryn Hendee; Megan Muyleart
Journal:  Sci Rep       Date:  2020-05-05       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.